The FDA has approved Female Health Company’s FC2 Female Condom (FC2), a woman-initiated barrier method that helps protect against unintended pregnancy, HIV/AIDS, and other sexually-transmitted infections (STIs). This approval is based on data from a randomized, double-blind, crossover, comparative trial of FC2 with FC1, which is Female Health Company’s first-generation FC Female Condom. The results showed FC2 to be safe and that the risk of FC2 failure modes during use was comparable to FC1.

For more information call (800) 635-0844 or visit